Global Subcutaneous Drug Delivery Devices Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028


Jul, 2022 | Report ID: 238046 | 165 | Medical Devices

The Subcutaneous Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Subcutaneous Drug Delivery Devices market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Subcutaneous Drug Delivery Devices global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Prefilled Injectable segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Subcutaneous Drug Delivery Devices include BD, Insulet Corporation, Enable Injections, West Pharmaceutical Services, Inc, and Ypsomed AG, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Subcutaneous Drug Delivery Devices market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Prefilled Injectable

Filled Injectable

Market segment by Application can be divided into

Hospitals

Clinics

Others

The key market players for global Subcutaneous Drug Delivery Devices market are listed below:

BD

Insulet Corporation

Enable Injections

West Pharmaceutical Services, Inc

Ypsomed AG

Elcam Medical

Amgen

Wilhelm Haselmeier

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Subcutaneous Drug Delivery Devices product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Subcutaneous Drug Delivery Devices, with price, sales, revenue and global market share of Subcutaneous Drug Delivery Devices from 2019 to 2022.

Chapter 3, the Subcutaneous Drug Delivery Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Subcutaneous Drug Delivery Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Subcutaneous Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Subcutaneous Drug Delivery Devices.

Chapter 13, 14, and 15, to describe Subcutaneous Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Subcutaneous Drug Delivery Devices Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Subcutaneous Drug Delivery Devices Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Prefilled Injectable

1.2.3 Filled Injectable

1.3 Market Analysis by Application

1.3.1 Overview: Global Subcutaneous Drug Delivery Devices Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Global Subcutaneous Drug Delivery Devices Market Size & Forecast

1.4.1 Global Subcutaneous Drug Delivery Devices Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Subcutaneous Drug Delivery Devices Sales in Volume (2017-2028)

1.4.3 Global Subcutaneous Drug Delivery Devices Price (2017-2028)

1.5 Global Subcutaneous Drug Delivery Devices Production Capacity Analysis

1.5.1 Global Subcutaneous Drug Delivery Devices Total Production Capacity (2017-2028)

1.5.2 Global Subcutaneous Drug Delivery Devices Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Subcutaneous Drug Delivery Devices Market Drivers

1.6.2 Subcutaneous Drug Delivery Devices Market Restraints

1.6.3 Subcutaneous Drug Delivery Devices Trends Analysis

2 Manufacturers Profiles

2.1 BD

2.1.1 BD Details

2.1.2 BD Major Business

2.1.3 BD Subcutaneous Drug Delivery Devices Product and Services

2.1.4 BD Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Insulet Corporation

2.2.1 Insulet Corporation Details

2.2.2 Insulet Corporation Major Business

2.2.3 Insulet Corporation Subcutaneous Drug Delivery Devices Product and Services

2.2.4 Insulet Corporation Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 Enable Injections

2.3.1 Enable Injections Details

2.3.2 Enable Injections Major Business

2.3.3 Enable Injections Subcutaneous Drug Delivery Devices Product and Services

2.3.4 Enable Injections Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 West Pharmaceutical Services, Inc

2.4.1 West Pharmaceutical Services, Inc Details

2.4.2 West Pharmaceutical Services, Inc Major Business

2.4.3 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product and Services

2.4.4 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Ypsomed AG

2.5.1 Ypsomed AG Details

2.5.2 Ypsomed AG Major Business

2.5.3 Ypsomed AG Subcutaneous Drug Delivery Devices Product and Services

2.5.4 Ypsomed AG Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Elcam Medical

2.6.1 Elcam Medical Details

2.6.2 Elcam Medical Major Business

2.6.3 Elcam Medical Subcutaneous Drug Delivery Devices Product and Services

2.6.4 Elcam Medical Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Amgen

2.7.1 Amgen Details

2.7.2 Amgen Major Business

2.7.3 Amgen Subcutaneous Drug Delivery Devices Product and Services

2.7.4 Amgen Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Wilhelm Haselmeier

2.8.1 Wilhelm Haselmeier Details

2.8.2 Wilhelm Haselmeier Major Business

2.8.3 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product and Services

2.8.4 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Subcutaneous Drug Delivery Devices Breakdown Data by Manufacturer

3.1 Global Subcutaneous Drug Delivery Devices Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Subcutaneous Drug Delivery Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Subcutaneous Drug Delivery Devices

3.4 Market Concentration Rate

3.4.1 Top 3 Subcutaneous Drug Delivery Devices Manufacturer Market Share in 2021

3.4.2 Top 6 Subcutaneous Drug Delivery Devices Manufacturer Market Share in 2021

3.5 Global Subcutaneous Drug Delivery Devices Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Subcutaneous Drug Delivery Devices Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Subcutaneous Drug Delivery Devices Market Size by Region

4.1.1 Global Subcutaneous Drug Delivery Devices Sales in Volume by Region (2017-2028)

4.1.2 Global Subcutaneous Drug Delivery Devices Revenue by Region (2017-2028)

4.2 North America Subcutaneous Drug Delivery Devices Revenue (2017-2028)

4.3 Europe Subcutaneous Drug Delivery Devices Revenue (2017-2028)

4.4 Asia-Pacific Subcutaneous Drug Delivery Devices Revenue (2017-2028)

4.5 South America Subcutaneous Drug Delivery Devices Revenue (2017-2028)

4.6 Middle East and Africa Subcutaneous Drug Delivery Devices Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Subcutaneous Drug Delivery Devices Sales in Volume by Type (2017-2028)

5.2 Global Subcutaneous Drug Delivery Devices Revenue by Type (2017-2028)

5.3 Global Subcutaneous Drug Delivery Devices Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Subcutaneous Drug Delivery Devices Sales in Volume by Application (2017-2028)

6.2 Global Subcutaneous Drug Delivery Devices Revenue by Application (2017-2028)

6.3 Global Subcutaneous Drug Delivery Devices Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)

7.2 North America Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)

7.3 North America Subcutaneous Drug Delivery Devices Market Size by Country

7.3.1 North America Subcutaneous Drug Delivery Devices Sales in Volume by Country (2017-2028)

7.3.2 North America Subcutaneous Drug Delivery Devices Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)

8.2 Europe Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)

8.3 Europe Subcutaneous Drug Delivery Devices Market Size by Country

8.3.1 Europe Subcutaneous Drug Delivery Devices Sales in Volume by Country (2017-2028)

8.3.2 Europe Subcutaneous Drug Delivery Devices Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)

9.2 Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)

9.3 Asia-Pacific Subcutaneous Drug Delivery Devices Market Size by Region

9.3.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)

10.2 South America Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)

10.3 South America Subcutaneous Drug Delivery Devices Market Size by Country

10.3.1 South America Subcutaneous Drug Delivery Devices Sales in Volume by Country (2017-2028)

10.3.2 South America Subcutaneous Drug Delivery Devices Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Type (2017-2028)

11.2 Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Application (2017-2028)

11.3 Middle East & Africa Subcutaneous Drug Delivery Devices Market Size by Country

11.3.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Subcutaneous Drug Delivery Devices Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Subcutaneous Drug Delivery Devices and Key Manufacturers

12.2 Manufacturing Costs Percentage of Subcutaneous Drug Delivery Devices

12.3 Subcutaneous Drug Delivery Devices Production Process

12.4 Subcutaneous Drug Delivery Devices Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Subcutaneous Drug Delivery Devices Typical Distributors

13.3 Subcutaneous Drug Delivery Devices Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Subcutaneous Drug Delivery Devices Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Subcutaneous Drug Delivery Devices Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. BD Basic Information, Manufacturing Base and Competitors

Table 4. BD Major Business

Table 5. BD Subcutaneous Drug Delivery Devices Product and Services

Table 6. BD Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Insulet Corporation Basic Information, Manufacturing Base and Competitors

Table 8. Insulet Corporation Major Business

Table 9. Insulet Corporation Subcutaneous Drug Delivery Devices Product and Services

Table 10. Insulet Corporation Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. Enable Injections Basic Information, Manufacturing Base and Competitors

Table 12. Enable Injections Major Business

Table 13. Enable Injections Subcutaneous Drug Delivery Devices Product and Services

Table 14. Enable Injections Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. West Pharmaceutical Services, Inc Basic Information, Manufacturing Base and Competitors

Table 16. West Pharmaceutical Services, Inc Major Business

Table 17. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product and Services

Table 18. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Ypsomed AG Basic Information, Manufacturing Base and Competitors

Table 20. Ypsomed AG Major Business

Table 21. Ypsomed AG Subcutaneous Drug Delivery Devices Product and Services

Table 22. Ypsomed AG Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Elcam Medical Basic Information, Manufacturing Base and Competitors

Table 24. Elcam Medical Major Business

Table 25. Elcam Medical Subcutaneous Drug Delivery Devices Product and Services

Table 26. Elcam Medical Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Amgen Basic Information, Manufacturing Base and Competitors

Table 28. Amgen Major Business

Table 29. Amgen Subcutaneous Drug Delivery Devices Product and Services

Table 30. Amgen Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Wilhelm Haselmeier Basic Information, Manufacturing Base and Competitors

Table 32. Wilhelm Haselmeier Major Business

Table 33. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product and Services

Table 34. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Global Subcutaneous Drug Delivery Devices Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)

Table 36. Global Subcutaneous Drug Delivery Devices Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 37. Market Position of Manufacturers in Subcutaneous Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 38. Global Subcutaneous Drug Delivery Devices Production Capacity by Company, (K Units): 2020 VS 2021

Table 39. Head Office and Subcutaneous Drug Delivery Devices Production Site of Key Manufacturer

Table 40. Subcutaneous Drug Delivery Devices New Entrant and Capacity Expansion Plans

Table 41. Subcutaneous Drug Delivery Devices Mergers & Acquisitions in the Past Five Years

Table 42. Global Subcutaneous Drug Delivery Devices Sales by Region (2017-2022) & (K Units)

Table 43. Global Subcutaneous Drug Delivery Devices Sales by Region (2023-2028) & (K Units)

Table 44. Global Subcutaneous Drug Delivery Devices Revenue by Region (2017-2022) & (USD Million)

Table 45. Global Subcutaneous Drug Delivery Devices Revenue by Region (2023-2028) & (USD Million)

Table 46. Global Subcutaneous Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 47. Global Subcutaneous Drug Delivery Devices Sales by Type (2023-2028) & (K Units)

Table 48. Global Subcutaneous Drug Delivery Devices Revenue by Type (2017-2022) & (USD Million)

Table 49. Global Subcutaneous Drug Delivery Devices Revenue by Type (2023-2028) & (USD Million)

Table 50. Global Subcutaneous Drug Delivery Devices Price by Type (2017-2022) & (USD/Unit)

Table 51. Global Subcutaneous Drug Delivery Devices Price by Type (2023-2028) & (USD/Unit)

Table 52. Global Subcutaneous Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 53. Global Subcutaneous Drug Delivery Devices Sales by Application (2023-2028) & (K Units)

Table 54. Global Subcutaneous Drug Delivery Devices Revenue by Application (2017-2022) & (USD Million)

Table 55. Global Subcutaneous Drug Delivery Devices Revenue by Application (2023-2028) & (USD Million)

Table 56. Global Subcutaneous Drug Delivery Devices Price by Application (2017-2022) & (USD/Unit)

Table 57. Global Subcutaneous Drug Delivery Devices Price by Application (2023-2028) & (USD/Unit)

Table 58. North America Subcutaneous Drug Delivery Devices Sales by Country (2017-2022) & (K Units)

Table 59. North America Subcutaneous Drug Delivery Devices Sales by Country (2023-2028) & (K Units)

Table 60. North America Subcutaneous Drug Delivery Devices Revenue by Country (2017-2022) & (USD Million)

Table 61. North America Subcutaneous Drug Delivery Devices Revenue by Country (2023-2028) & (USD Million)

Table 62. North America Subcutaneous Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 63. North America Subcutaneous Drug Delivery Devices Sales by Type (2023-2028) & (K Units)

Table 64. North America Subcutaneous Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 65. North America Subcutaneous Drug Delivery Devices Sales by Application (2023-2028) & (K Units)

Table 66. Europe Subcutaneous Drug Delivery Devices Sales by Country (2017-2022) & (K Units)

Table 67. Europe Subcutaneous Drug Delivery Devices Sales by Country (2023-2028) & (K Units)

Table 68. Europe Subcutaneous Drug Delivery Devices Revenue by Country (2017-2022) & (USD Million)

Table 69. Europe Subcutaneous Drug Delivery Devices Revenue by Country (2023-2028) & (USD Million)

Table 70. Europe Subcutaneous Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 71. Europe Subcutaneous Drug Delivery Devices Sales by Type (2023-2028) & (K Units)

Table 72. Europe Subcutaneous Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 73. Europe Subcutaneous Drug Delivery Devices Sales by Application (2023-2028) & (K Units)

Table 74. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Region (2017-2022) & (K Units)

Table 75. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Region (2023-2028) & (K Units)

Table 76. Asia-Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2017-2022) & (USD Million)

Table 77. Asia-Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2023-2028) & (USD Million)

Table 78. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 79. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Type (2023-2028) & (K Units)

Table 80. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 81. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Application (2023-2028) & (K Units)

Table 82. South America Subcutaneous Drug Delivery Devices Sales by Country (2017-2022) & (K Units)

Table 83. South America Subcutaneous Drug Delivery Devices Sales by Country (2023-2028) & (K Units)

Table 84. South America Subcutaneous Drug Delivery Devices Revenue by Country (2017-2022) & (USD Million)

Table 85. South America Subcutaneous Drug Delivery Devices Revenue by Country (2023-2028) & (USD Million)

Table 86. South America Subcutaneous Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 87. South America Subcutaneous Drug Delivery Devices Sales by Type (2023-2028) & (K Units)

Table 88. South America Subcutaneous Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 89. South America Subcutaneous Drug Delivery Devices Sales by Application (2023-2028) & (K Units)

Table 90. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Region (2017-2022) & (K Units)

Table 91. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Region (2023-2028) & (K Units)

Table 92. Middle East & Africa Subcutaneous Drug Delivery Devices Revenue by Region (2017-2022) & (USD Million)

Table 93. Middle East & Africa Subcutaneous Drug Delivery Devices Revenue by Region (2023-2028) & (USD Million)

Table 94. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Type (2017-2022) & (K Units)

Table 95. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Type (2023-2028) & (K Units)

Table 96. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Application (2017-2022) & (K Units)

Table 97. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Application (2023-2028) & (K Units)

Table 98. Subcutaneous Drug Delivery Devices Raw Material

Table 99. Key Manufacturers of Subcutaneous Drug Delivery Devices Raw Materials

Table 100. Direct Channel Pros & Cons

Table 101. Indirect Channel Pros & Cons

Table 102. Subcutaneous Drug Delivery Devices Typical Distributors

Table 103. Subcutaneous Drug Delivery Devices Typical Customers

List of Figures

Figure 1. Subcutaneous Drug Delivery Devices Picture

Figure 2. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type in 2021

Figure 3. Prefilled Injectable

Figure 4. Filled Injectable

Figure 5. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application in 2021

Figure 6. Hospitals

Figure 7. Clinics

Figure 8. Others

Figure 9. Global Subcutaneous Drug Delivery Devices Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028

Figure 10. Global Subcutaneous Drug Delivery Devices Revenue and Forecast (2017-2028) & (USD Million)

Figure 11. Global Subcutaneous Drug Delivery Devices Sales (2017-2028) & (K Units)

Figure 12. Global Subcutaneous Drug Delivery Devices Price (2017-2028) & (USD/Unit)

Figure 13. Global Subcutaneous Drug Delivery Devices Production Capacity (2017-2028) & (K Units)

Figure 14. Global Subcutaneous Drug Delivery Devices Production Capacity by Geographic Region: 2022 VS 2028

Figure 15. Subcutaneous Drug Delivery Devices Market Drivers

Figure 16. Subcutaneous Drug Delivery Devices Market Restraints

Figure 17. Subcutaneous Drug Delivery Devices Market Trends

Figure 18. Global Subcutaneous Drug Delivery Devices Sales Market Share by Manufacturer in 2021

Figure 19. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Manufacturer in 2021

Figure 20. Subcutaneous Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 21. Top 3 Subcutaneous Drug Delivery Devices Manufacturer (Revenue) Market Share in 2021

Figure 22. Top 6 Subcutaneous Drug Delivery Devices Manufacturer (Revenue) Market Share in 2021

Figure 23. Global Subcutaneous Drug Delivery Devices Sales Market Share by Region (2017-2028)

Figure 24. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2017-2028)

Figure 25. North America Subcutaneous Drug Delivery Devices Revenue (2017-2028) & (USD Million)

Figure 26. Europe Subcutaneous Drug Delivery Devices Revenue (2017-2028) & (USD Million)

Figure 27. Asia-Pacific Subcutaneous Drug Delivery Devices Revenue (2017-2028) & (USD Million)

Figure 28. South America Subcutaneous Drug Delivery Devices Revenue (2017-2028) & (USD Million)

Figure 29. Middle East & Africa Subcutaneous Drug Delivery Devices Revenue (2017-2028) & (USD Million)

Figure 30. Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2017-2028)

Figure 31. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type (2017-2028)

Figure 32. Global Subcutaneous Drug Delivery Devices Price by Type (2017-2028) & (USD/Unit)

Figure 33. Global Subcutaneous Drug Delivery Devices Sales Market Share by Application (2017-2028)

Figure 34. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application (2017-2028)

Figure 35. Global Subcutaneous Drug Delivery Devices Price by Application (2017-2028) & (USD/Unit)

Figure 36. North America Subcutaneous Drug Delivery Devices Sales Market Share by Type (2017-2028)

Figure 37. North America Subcutaneous Drug Delivery Devices Sales Market Share by Application (2017-2028)

Figure 38. North America Subcutaneous Drug Delivery Devices Sales Market Share by Country (2017-2028)

Figure 39. North America Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2017-2028)

Figure 40. United States Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Canada Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Mexico Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Europe Subcutaneous Drug Delivery Devices Sales Market Share by Type (2017-2028)

Figure 44. Europe Subcutaneous Drug Delivery Devices Sales Market Share by Application (2017-2028)

Figure 45. Europe Subcutaneous Drug Delivery Devices Sales Market Share by Country (2017-2028)

Figure 46. Europe Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2017-2028)

Figure 47. Germany Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. France Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. United Kingdom Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Russia Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Italy Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 52. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Market Share by Region (2017-2028)

Figure 53. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Market Share by Application (2017-2028)

Figure 54. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Market Share by Region (2017-2028)

Figure 55. Asia-Pacific Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2017-2028)

Figure 56. China Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Japan Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Korea Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. India Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. Southeast Asia Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Australia Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South America Subcutaneous Drug Delivery Devices Sales Market Share by Type (2017-2028)

Figure 63. South America Subcutaneous Drug Delivery Devices Sales Market Share by Application (2017-2028)

Figure 64. South America Subcutaneous Drug Delivery Devices Sales Market Share by Country (2017-2028)

Figure 65. South America Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2017-2028)

Figure 66. Brazil Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Argentina Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Market Share by Type (2017-2028)

Figure 69. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Market Share by Application (2017-2028)

Figure 70. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Market Share by Region (2017-2028)

Figure 71. Middle East & Africa Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2017-2028)

Figure 72. Turkey Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Egypt Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Saudi Arabia Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. South Africa Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Devices in 2021

Figure 77. Manufacturing Process Analysis of Subcutaneous Drug Delivery Devices

Figure 78. Subcutaneous Drug Delivery Devices Industrial Chain

Figure 79. Sales Channel: Direct Channel vs Indirect Channel

Figure 80. Methodology

Figure 81. Research Process and Data Source

Sample Request is not available